Exvastat wins 3.6m euro grant for COVID-19 trial
The firm will work with Vrije Universitat to produce a reformulated version of imatinib and test it in COVID-19 patients
Read More
Tag: Exvastat
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
